ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
224.46
-2.28 (-1.01%)
Aug 14, 2026, 4:00 PM EDT - Market closed

ResMed Cash Flow Statement

Millions USD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Income
1,5231,4011,021897.56779.44
Depreciation & Amortization
244.15210.34188.76172.51158.3
Other Amortization
-25.4727.4525.0635.55
Asset Writedown & Restructuring Costs
--33.249.18-
Loss (Gain) From Sale of Investments
10.6610.34.05-9.9212.2
Loss (Gain) on Equity Investments
-2.38-3.641.8510.148.49
Stock-Based Compensation
104.3591.6680.1871.1465.26
Other Operating Activities
----20.23-
Change in Accounts Receivable
-96.78-76.68-134.28-106.5119.35
Change in Inventory
-9.92-80.17172.2-248.83-311.68
Change in Accounts Payable
172.7290.96122.0731.34-247.63
Change in Other Net Operating Assets
-140.2682.63-115.21-138.13-168.11
Operating Cash Flow
1,8061,7521,401693.3351.15
Operating Cash Flow Growth
3.10%25.00%102.11%97.44%-52.34%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Capital Expenditures
-156.29-89.87-99.46-119.67-134.84
Cash Acquisitions
-350.72-139.25-133.46-1,013-42.78
Sale (Purchase) of Intangibles
-20.89-10.78-15.4-14.33-21.2
Investment in Securities
-25.78-1.79-11.77-28.29-13.92
Other Investing Activities
8.4841.63-9.715.2-17.18
Investing Cash Flow
-545.2-200.05-269.78-1,160-229.92

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Long-Term Debt Issued
--1051,070288
Long-Term Debt Repaid
-10-40-835-405-166
Net Debt Issued (Repaid)
-10-40-730665122
Issuance of Common Stock
74.574.4453.0949.1447.38
Repurchase of Common Stock
-721.87-318.1-158.77-30.63-52.41
Common Dividends Paid
-349.66-310.88-282.32-258.28-245.34
Other Financing Activities
--11.71-1.29-2.36-
Financing Cash Flow
-1,007-606.25-1,119422.87-128.36

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Foreign Exchange Rate Adjustments
6.1825.8-1.72-2.15-14.43
Net Cash Flow
259.78971.0910.47-45.82-21.57

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
1,6501,6621,302573.63216.31
Free Cash Flow Growth
-0.73%27.65%126.94%165.19%-65.88%
Free Cash Flow Margin
29.18%32.29%27.79%13.58%6.04%
Free Cash Flow Per Share
11.2911.288.823.891.47
Levered Free Cash Flow
939.251,2081,185400.59127.68
Unlevered Free Cash Flow
939.251,2081,216432.55141.63

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash Interest Paid
-28.4245.7147.3822.31
Cash Income Tax Paid
-214.01278.4216.87478.12
Change in Working Capital
-74.2416.7444.78-462.13-708.08
SEC Filings: 10-K · 10-Q